Skip to main content
Clinical Trials/JPRN-UMIN000011837
JPRN-UMIN000011837Completed未知

Efficacy and safety of levofloxacin infusion in patients with NHCAP categorized as group B or C according to the JRS Guidelines for the Management of Hospital-Acquired Pneumonia in Adults - Efficacy and safety of levofloxacin infusion in patients with NHCAP categorized as group B or C according to the JRS Guidelines for the Management of Hospital-Acquired Pneumonia in Adults

Department of Respiratory Medicine,University of Occupational and Environmental Health, Japan0 sites60 target enrollmentStarted: October 31, 2013Last updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1.Patients receiving other treatments with clinical efficacy 2.Contraindication for levofloxacin 3.Patients deemed ineligible by the attending physicians for various reasons.

Investigators

Sponsor
Department of Respiratory Medicine,University of Occupational and Environmental Health, Japan

Similar Trials

Completed
Not Applicable
Efficacy and Safety of treatment with Levofloxacin for Community-acquired PneumoniaCommunity-acquired pneumonia in adults
JPRN-UMIN000008677Second Division, Department of Internal Medicine, Hamamatsu university school of medicine300
Completed
Not Applicable
Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in KoreaHelicobacter pylori infection
JPRN-UMIN000015375Severance Hospital, Yonsei University200
Recruiting
Phase 4
Pharmacokinetic study and safety of levofloxacin in pediatric tuberculosis treatmentMulti&#45drug resistant tuberculosisIsoniazid resistant tuberculosispatient with toxicity from the first line antituberculosisMDR&#45Hr&#45Toxicity from the first line anti&#45LevofloxacinTB
TCTR20190515001Center of Excellence for Pediatric Infectious Diseases and Vaccines20
Recruiting
Not Applicable
Comparison of Levofloxacin/Colistin with Levofloxacin/high dose Ampicillin-sulbactam infusion in treatment of Ventilator-Associated Pneumonia due to multi drug resistant Acinetobacter
IRCT20120703010178N15Shahid Beheshti University of Medical Sciences56
Active, not recruiting
Phase 1
Comparison of the Safety of Intracameral Levofloxacin to intracameral Cefuroxime for the prevention of endophthalmitis in cataract surgery (SILC) - Safety of intracameral levofloxacin in cataract surgery (version 2)Cataracts and endophthalmitisMedDRA version: 12Level: PTClassification code 10006379Term: Cataract SurgeryMedDRA version: 12Level: LLTClassification code 10014801Term: Endophthalmitis
EUCTR2009-014054-14-GBGuys' and St Thomas' NHS Foundation Trust, Joint Clinical Trials Office30